Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder thought to be associated with mitochondrial dysfunction. Loss of function mutations in the putative mitochondrial protein PINK1 (PTEN-induced kinase 1) have been linked to familial forms of PD, but the relation of PINK1 to mammalian mitochondrial function remains unclear. Here, we report that germline deletion of the PINK1 gene in mice significantly impairs mitochondrial functions. Quantitative electron microscopic studies of the striatum in PINK1 −/− mice at 3–4 and 24 months revealed no gross changes in the ultrastructure or the total number of mitochondria, although the number of larger mitochondria is selectively increased. Functional assays showed impaired mitochondrial respiration in the striatum but not in the cerebral cortex at 3–4 months of age, suggesting specificity of this defect for dopaminergic circuitry. Aconitase activity associated with the Krebs cycle is also reduced in the striatum of PINK1 −/− mice. Interestingly, mitochondrial respiration activities in the cerebral cortex are decreased in PINK1 −/− mice at 2 years compared with control mice, indicating that aging can exacerbate mitochondrial dysfunction in these mice. Furthermore, mitochondrial respiration defects can be induced in the cerebral cortex of PINK1 −/− mice by cellular stress, such as exposure to H 2 O 2 or mild heat shock. Together, our findings demonstrate that mammalian PINK1 is important for mitochondrial function and provides critical protection against both intrinsic and environmental stress, suggesting a pathogenic mechanism by which loss of PINK1 may lead to nigrostriatal degeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, when PINK1 is mutated, it loses its function, which means there is no longer any protection against ROS [141].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [141]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Gautier et al, 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“The recent discovery of recessively inherited loss of function mutations in three distinct genes that are linked to early onset parkinsonism (7–9) has provided a unique opportunity to create in vivo models to identify early pathogenic changes, which may ultimately lead to neurodegeneration (10).”
Self-citationChronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683 · cited 1×
“Accidental exposure to mitochondrial toxins leads to symptoms resembling those of PD via the selective death of dopaminergic neuron (5, 6).”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 1×
“Bioinformatics analysis reveals that PINK1 is a putative serine-threonine kinase with a mitochondrial targeting motif at its N-terminal end (9).”
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · cited 1×
“A growing number of clinical and experimental reports implicate mitochondrial dysfunctions and oxidative stress in the pathogenesis of PD (1, 2).”
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 2×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 3×
“In fact, two recent articles showed dramatic functional and structural impairments of mitochondria in Drosophila bearing null mutations for dPINK1 (14, 15).”
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Self-citationThe PINK1/Parkin pathway regulates mitochondrial morphology
Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., & Pallanck, L. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709336105 · Cited by 885 · cited 2×
“How can one explain such a protective role of PINK1 in mitochondria? One possibility, raised by studies in flies, is that PINK1 is involved in the regulation of mitochondrial fission and fusion (16, 17).”
Cited by
Items 301–400 of 722
Salazar, C., Ruiz‐Hincapie, P., & Ruíz, L. M. (2018) · Cells · doi:10.3390/cells7100154 · Cited by 55
Autophagy and LRRK2 in the Aging Brain
Albanese, F., Novello, S., & Morari, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01352 · Cited by 55
Hyperexcitable Substantia Nigra Dopamine Neurons in PINK1- and HtrA2/Omi-Deficient Mice
Bishop, M. W., Chakraborty, S., Matthews, G. A. C., Dougalis, A., Wood, N. W., Festenstein, R., & Ungless, M. A. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00466.2010 · Cited by 53
“In PINK1deficient mice, however, mitochondrial functional defects have been shown to be relatively subtle and fail to create a major energy crisis (Gautier et al. 2008).”
BackgroundInfluentialPINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis
Akundi, R. S., Zhi, L., & Büeler, H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.034 · Cited by 51
“…prevention of mitochondrial degeneration (Akundi et al., 2011; Canet-Aviles et al., 2004; Chen et al., 2010; Clark et al., 2006; Deng et al., 2008; Gautier et al., 2008; Gegg et al., 2009; Greene et al., 2005; Haque et al., 2008; Inden et al., 2006; Jiang et al., 2004; Kim et al., 2005b; Meulener…”
BackgroundWu, M., Zhang, C., Xie, M., Zhen, Y., Lai, B., Liu, J., Qiao, L., Liu, S., & Shi, D. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.029 · Cited by 56
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 55
Elevated plasma succinate in PTEN, SDHB, and SDHD mutation–positive individuals
Hobert, J. A., Mester, J. L., Moline, J., & Eng, C. (2012) · Genetics in Medicine · doi:10.1038/gim.2011.63 · Cited by 51
Promising use of metformin in treating neurological disorders: biomarker-guided therapies
Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385286 · Cited by 53
“…production is underscored by some autosomal recessive forms of hereditary early-onset PD, whose genes (Parkin and PTEN-induced putative kinase 1 (PINK1)) have a role in mitochondrial bioenergetics and oxidative stress (Gautier et al., 2008; Larsen et al., 2018; Nicoletti et al., 2021).”
BackgroundAbeliovich, A. (2010) · Nature · doi:10.1038/463744a · Cited by 51
The emerging multifaceted role of PINK1 in cancer biology
Wang, M., Luan, S., Fan, X., Wang, J., Huang, J., Gao, X., & Han, D. (2022) · Cancer Science · doi:10.1111/cas.15568 · Cited by 50
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 53
Lin, W., Wadlington, N. L., Chen, L., Zhuang, X., Brorson, J. R., & Kang, U. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2286-13.2014 · Cited by 45
“Well characterized deficits include decreased mitochondrial membrane potential, reduced complex I activity, lowered ATP production, increased oxidative stress, and abnormal mitochondrial morphology such as fragmented cristae (Clark et al., 2006; Park et al., 2006; Gautier et al., 2008; Liu et al., 2009; Yao et al., 20…”
BackgroundLoss of PINK1 Impairs Stress-Induced Autophagy and Cell Survival
Parganlija, D., Klinkenberg, M., Domínguez-Bautista, J., Hetzel, M., Gispert, S., Chimi, M. A., Dröse, S., Mai, S., Brandt, U., Auburger, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095288 · Cited by 46
“Mitochondrial morphology was not altered by PINK1 knockdown in untreated SH-SY5Y cells or cells under trophic stress, correlating with earlier works that observed in human cells just little or no effect of PINK1 downregulation [3,19,21,31,32] or upregulation [33] on mitochondrial morphology.”
BackgroundParkinson's disease-associated pathogenic VPS35 mutation causes complex I deficits
Zhou, L., Wang, W., Hoppel, C., Liu, J., & Zhu, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.032 · Cited by 49
“For example, abundant evidence shows that complex I enzymatic activity is reduced in PINK1-deficient mice and flies [34, 35].”
BackgroundMitochondrial protein dysfunction in pathogenesis of neurological diseases
Wang, L., Yang, Z., He, X., Pu, S., Yang, C., Wu, Q., Zhou, Z., Cen, X., & Zhao, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.974480 · Cited by 49
“Among all, PINK1Parkin-mediated mitophagy is the most heavily studied and best-understood mitophagy pathway (Gautier et al., 2008; Narendra et al., 2008; Palikaras et al., 2018; Chu, 2019; Cai and Jeong, 2020).”
BackgroundXing, X., Tang, Y., Xu, H., Qin, H., Liu, Y., Zhang, W., Chen, A., & Zhu, B. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.02965-20 · Cited by 48
Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease
Lucchesi, M., Biso, L., Bonaso, M., Longoni, B., Buchignani, B., Battini, R., Santorelli, F. M., Doccini, S., & Scarselli, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094451 · Cited by 51
“…consanguinity from Netherlands with early-onset parkinsonism [69]; since then, at least 27 variants of DJ ‐ 1 have been registered. animal models show decreased activity of oxidative phosphorylation, reduced mitochondrial respiration and mitochondrial morphological abnormalities [27,33–36].”
Sirt3 regulates mitophagy level to promote diabetic corneal epithelial wound healing
Hu, J., Kan, T., & Hu, X. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.02.011 · Cited by 49
Subrahmanian, N., & LaVoie, M. J. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147434 · Cited by 51
“While a more generalized mitochondrial defect in Pink1-null mouse brain has also been suggested (Gautier et al., 2008), selective decreases in CI activity were first reported in mouse brain tissue and Drosophila brain-enriched and muscle-enriched mitochondrial homogenates (Morais et al., 2009).”
BackgroundGenetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 54
“One KO model contains a targeted deletion of exons 4–7, whereas a second model employed conditional RNA interference to silence PINK1 expression.143,178 Both PINK1 models do not reveal obvious locomotor abnormalities, protein inclusions or aggregates, or loss of nigrostriatal dopaminergic neurons with age.143,178–180…”
BackgroundFunctions and characteristics of PINK1 and Parkin in cancer
Matsuda, S., Nakanishi, A., Minami, A., Wada, Y., & Kitagishi, Y. (2015) · Frontiers in bioscience · doi:10.2741/4321 · Cited by 52
PINK1 heterozygous mutations induce subtle alterations in dopamine‐dependent synaptic plasticity
Madeo, G., Schirinzi, T., Martella, G., Latagliata, E. C., Puglisi, F., Shen, J., Valente, E. M., Federici, M., Mercuri, N. B., Puglisi‐Allegra, S., et al. (2013) · Movement Disorders · doi:10.1002/mds.25724 · Cited by 49
“through dysregulation of the mitochondrial permeability transition pore opening.(58) Thus, it is conceivable”
Self-citationPINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates
Matsui, H., Gavinio, R., Asano, T., Uemura, N., Ito, H., Taniguchi, Y., Kobayashi, Y., Maki, T., Shen, J., Takeda, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt095 · Cited by 47
“5A) consistent with previous studies in PINK1-deficient mice (7,38) and PARK6 patient fibroblasts (32).”
Self-citationSun, Y., Pham, A. N., Hare, D. J., & Waite, T. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00859 · Cited by 49
“Previous studies also reported that the presence of DA quinones may also aggravate oxidative stress as a result of the inactivation in the electron transport chain of mitochondrial complexes I and III and the subsequent leakage of electrons from the respiratory chain (Stokes et al., 1999; Adam-Vizi, 2005; Lin and Beal…”
BackgroundDiedrich, M., Kitada, T., Nebrich, G., Koppelstaetter, A., Shen, J., Zabel, C., Klose, J., & Mao, L. (2011) · Proteome Science · doi:10.1186/1477-5956-9-59 · Cited by 45
“In our previous communication, we showed that the loss-of-function mutation of PINK1 leads to brain mitochondrial dysfunction and heightened susceptibility of neurons to oxidative stress [21].”
BackgroundInfluentialSelf-citationBalance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 50
Martella, G., Madeo, G., Maltese, M., Vanni, V., Puglisi, F., Ferraro, E., Schirinzi, T., Valente, E. M., Bonanni, L., Shen, J., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.12.020 · Cited by 48
“…knockout mice showed a partial decrease in complex I activity, without gross changes in the striatal mitochondria ultrastructure (Park et al., 2006; Gautier et al., 2008), resembling the decrease in mitochondrial complex I activity observed infibroblasts frompatients carrying PINK1 mutations…”
BackgroundSelf-citationLoss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction
Zhi, L., Qin, Q., Muqeem, T., Seifert, E. L., Liu, W., Zheng, S., Li, C., & Zhang, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.025 · Cited by 47
“Mitochondria isolated from striatum or whole brain of aged PINK1 KO mouse shows defects in complex I (Gautier et al., 2008; Liu et al., 2011; Morais et al., 2014; Morais et al., 2009).”
BackgroundInfluentialMartella, G., Platania, P., Vita, D., Sciamanna, G., Cuomo, D., Tassone, A., Tscherter, A., Kitada, T., Bonsi, P., Shen, J., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.11.001 · Cited by 46
“In fact, mutations in both genes lead to cellular energetic defects, such as ATP depletion, enhanced sensitivity to oxidative stress (Gautier et al., 2008).”
Self-citationMitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
Tassone, A., Meringolo, M., Ponterio, G., Bonsi, P., Schirinzi, T., & Martella, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087221 · Cited by 47
Loss-of-Function Rodent Models for Parkin and PINK1
Oliveras-Salv´, M., Van Rompuy, A.-S., Heeman, B., Van den Haute, C., & Baekelandt, V. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11041 · Cited by 43
“In general, no gross changes were noticed in mitochondrial number and ultrastructure when analyzing the striatum of PINK1 knockout mice at 3 and 24 months old [115].”
BackgroundInfluentialWhat have we learned from Drosophila models of Parkinson’s disease?
Guo, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84001-4 · Cited by 51
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 45
Knuppertz, L., & Osiewacz, H. D. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.01.003 · Cited by 47
“Similarly, mitochondria from the striatum of Pink1 knockout mice are deficient in mitochondrial respiratory chain complexes I and II (Gautier et al., 2008).”
BackgroundZabel, C., Nguyen, H. P., Hin, S. C., Hartl, D., Mao, L., & Klose, J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.08.008 · Cited by 46
Genetic variations associated with six-white-point coat pigmentation in Diannan small-ear pigs
Lü, M., Han, X.-M., Ma, Y., Irwin, D. M., Gao, Y., Deng, J.-K., Adeola, A. C., Xie, H., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep27534 · Cited by 47
Targeting autophagy and mitophagy for mitochondrial diseases treatment
Paz, M. V., Cotán, D., Garrido‐Maraver, J., Cordero, M. D., Oropesa-Ávila, M., de la Mata, M., Pavón, A. D., de Lavera, I., Alcocer‐Gómez, E., & Sánchez-Alcázar, J. A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1101068 · Cited by 44
“Experiments with PINK1 mice showed impaired mitochondrial respiration and an increase in large mitochondria, which can be related with the function of PINK1 to promote fission and mitophagy.[54] These effects were exacerbated with age, suggesting that mitophagy also has an important role in aging.”
BackgroundEnfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento
de Pereira, U. T., Marín, D. S., Villada, H. C., de Pereira, U. T., Ibarra, M., Grupo de Investigación “Applied Neuroscience”, N. R., Gámez-Cárdenas, M., & de Pereira, U. T. (2018) · Salud UIS · doi:10.18273/revsal.v50n1-2018008 · Cited by 71
Bose, A., & Beal, M. F. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14264 · Cited by 47
Autophagy in the Pathogenesis of Pulmonary Disease
Araya, J., Hara, H., & Kuwano, K. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.1118 · Cited by 45
The role of mitochondrial-related nuclear genes in age-related common disease
Li, H., Slone, J. D., & Huang, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.012 · Cited by 44
PINK1 as a Molecular Checkpoint in the Maintenance of Mitochondrial Function and Integrity
Koh, H., & Chung, J. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0100-8 · Cited by 40
Bus, C., Zizmare, L., Feldkaemper, M. P., Geisler, S., Zarani, M., Schaedler, A., Klose, F., Admard, J., Mageean, C. J., Arena, G., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101797 · Cited by 44
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Kincses, Z. T., & Vécsei, L. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00150.x · Cited by 45
“The role of PINK1 in the pathogenesis of PD may be related to defective oxidative phosporylation in consequence of changes in the phosphorylation of key mitochondrial proteins of the respiratory complexes [159].”
BackgroundSong, L., Shan, Y., Lloyd, K. C. K., & Cortopassi, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds365 · Cited by 39
“A growing number of clinical and experimental studies indicate that mitochondrial dysfunction contributes to the pathogenesis of PD (1,2).”
BackgroundSeita, Y., Tsukiyama, T., Iwatani, C., Tsuchiya, H., Matsushita, J., Azami, T., Okahara, J., Nakamura, S., Hayashi, Y., Hitoshi, S., et al. (2016) · Scientific Reports · doi:10.1038/srep24868 · Cited by 40
The complex interplay between autophagy and cell death pathways
Ploumi, C., Papandreou, M.-E., & Tavernarakis, N. (2022) · Biochemical Journal · doi:10.1042/bcj20210450 · Cited by 39
Reinforcing mitochondrial functions in aging brain: An insight into Parkinson's disease therapeutics
Chandra, G., Shenoi, R. A., Anand, R., Rajamma, U., & Mohanakumar, K. P. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.12.004 · Cited by 39
Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases
Shen, J. (2010) · Neurodegenerative Diseases · doi:10.1159/000285511 · Cited by 38
“In addition, our studies have further shown that loss of PINK1 or Parkin impairs mitochondrial function [36, 37] .”
Self-citationUm, J., Lee, K., Kim, Y.-Y., Lee, D., Kim, E.-M., Kim, D., & Yun, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010219 · Cited by 39
“To test whether berberine improves mitochondrial function, we treated PINK1 knockout (PNK1 KO) MEFs, a well-known model for mitochondrial dysfunction exhibiting decreased mitochondrial membrane potential, elevated mitochondrial ROS, and decreased mitochondrial respiration [28,29], with berberine.”
BackgroundAnderson, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043300 · Cited by 44
“Importantly, exogenous melatonin promotes PINK1 accumulation on the mitochondrial membrane, as shown in neurons [148], indicating that melatonin not only upregulates the beneficial effects of PINK1 regarding autophagy, mitophagy, and protection against oxidative stress, but would also prevent the consequences of suppr…”
BackgroundFlies with Parkinson's disease
Vanhauwaert, R., & Verstreken, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.020 · Cited by 39
Nitric Oxide Induction of Parkin Translocation in PTEN-induced Putative Kinase 1 (PINK1) Deficiency
Han, J., Kang, M., Kim, K., Han, P., Kim, H., Ha, J., & Son, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624767 · Cited by 38
Relative importance of βcyto- and γcyto-actin in primary mouse embryonic fibroblasts
Patrinostro, X., O’Rourke, A. R., Chamberlain, C. M., Moriarity, B. S., Perrin, B. J., & Ervasti, J. M. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-07-0503 · Cited by 42
“…will be challenging to answer, given that ablation of functionally disparate Volume 28 March 15, 2017 β-Actin is essential in primary cells | 777 genes in MEFs affects cellular ATP levels independent of corresponding defects in mitochondrial respiration (Gautier et al., 2008; Giaime et al., 2012).”
BackgroundFrank, C. A., Wang, X., Collins, C. A., Rodal, A. A., Yuan, Q., Verstreken, P., & Dickman, D. K. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3261-13.2013 · Cited by 44
Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1
Amo, T., Saiki, S., Sawayama, T., Sato, S., & Hattori, N. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.045 · Cited by 37
The role of PTEN-induced kinase 1 in mitochondrial dysfunction and dynamics
Thomas, K. J., & Cookson, M. R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.018 · Cited by 38
Ma, P., Yun, J., Deng, H., & Guo, M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-04-0243 · Cited by 37
“Studies employing mammalian cell culture and other animal models revealed that the regulation of mitochondrial integrity and function by the pink1/parkin pathway is well conserved (Palacino et al., 2004; Exner et al., 2007; Gautier et al., 2008; Flinn et al., 2009; Lutz et al., 2009; Yu et al., 2011).”
BackgroundAgnihotri, S. K., Sun, L., Yee, B. K., Shen, R., Akundi, R. S., Zhi, L., Duncan, M. J., Cass, W. A., & Büeler, H. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.006 · Cited by 38
“PINK1 and Parkin mice are therefore similarly unaffected in terms of affective behavior despite mitochondrial defects in both mutant mouse lines [18,41,58,59].”
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease
Ahuja, M., Kaidery, N. A., Dutta, D., Attucks, O. C., Kazakov, E. H., Gazaryan, I. G., Matsumoto, M., Igarashi, K., Sharma, S. M., & Thomas, B. (2022) · Antioxidants · doi:10.3390/antiox11091780 · Cited by 38
Zhu, J., Xu, F., Lai, H., Yuan, H., Li, X., Hu, J., Li, W., Liu, L., & Wang, C. (2023) · Communications Biology · doi:10.1038/s42003-023-05570-y · Cited by 37
“Similarly, ACO2 activity was signi fi cantly reduced in striatum (STR) of PINK1-knockout mice 30 .”
Beyond Mitophagy: Cytosolic PINK1 as a Messenger of Mitochondrial Health
Steer, E. K., Dail, M. K., & Chu, C. T. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6206 · Cited by 35
“PINK1 deficiency also affects substrate availability through regulation of the plasma membrane glucose transporter (33), components of the citric acid cycle (35), or the ability of mitochondrial calcium to stimulate ATP synthesis (45).”
Qi, Z., Yang, W., Liu, Y., Cui, T., Gao, H., Duan, C., Lu, L., Zhao, C., Zhao, H., & Yang, H. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.03.023 · Cited by 38
“, 2010) or antagonizing oxidative stress (Gautier et al., 2008; Wang et al., 2006) and neurotoxins (Deng et al.”
Protein recycling pathways in neurodegenerative diseases
Fecto, F., Esengul, Y. T., & Siddique, T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt243 · Cited by 37
“Consistent with this, it has been shown that there is an accumulation of damaged mitochondria in knockout models of PINK1 and parkin [74-76].”
BackgroundStructure-based design and characterization of Parkin-activating mutations
Stevens, M., Croteau, N., Eldeeb, M. A., Antico, O., Zeng, Z. W., Toth, R. L., Durcan, T. M., Springer, W., Fon, E. A., Muqit, M. M. K., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201419 · Cited by 34
“Likewise, PINK1 KO mice also do not display neurodegeneration, but similar to PRKN KO exhibit marked mitochondrial defects (Gautier et al, 2008).”
To Eat or Not to Eat: Neuronal Metabolism, Mitophagy, and Parkinson's Disease
Gusdon, A. M., & Chu, C. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3763 · Cited by 35
“Interestingly, aged PINK1 knockout mice demonstrate decreased complex I-, II-, or IV-supported mitochondrial respiration in the striatum but not in the cortex (17, 20).”
BackgroundGene therapy targeting mitochondrial pathway in Parkinson’s disease
Choong, C., & Mochizuki, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1616-4 · Cited by 35
Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Siddall, H. K., Yellon, D. M., Ong, S., Mukherjee, U., Burke, N., Hall, A. R., Angelova, P. R., Ludtmann, M. H. R., Deas, E., Davidson, S. M., et al. (2013) · PLoS ONE · doi:10.1371/annotation/94fd6502-4b2d-409c-8836-66fe6ebc03ab · Cited by 34
Stauch, K. L., Villeneuve, L. M., Purnell, P. R., Ottemann, B. M., Emanuel, K. M., & Fox, H. S. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600005 · Cited by 35
“Striatal mitochondria from Pink1 KO mice show decreased mitochondrial respiration; however, the mice have a mild phenotype with no gross morphological changes [33].”
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
Biosa, A., Sánchez-Martínez, Á., Filograna, R., Terriente-Félix, A., Alam, S. M., Beltramini, M., Bubacco, L., Bisaglia, M., & Whitworth, A. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy069 · Cited by 35
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 37
N-Terminal Truncated UCH-L1 Prevents Parkinson's Disease Associated Damage
Kim, H.-J., Kim, H. J., Jeong, J.-E., Baek, J. Y., Jeong, J., Kim, S. Y., Kim, Y.-M., Kim, Y., Nam, J. H., Huh, S. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099654 · Cited by 35
Oxidative Stress and Regulation of Pink1 in Zebrafish (Danio rerio)
Priyadarshini, M., Orosco, L. A., & Panula, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081851 · Cited by 34
“The loss of PINK1 in mice is associated with reduced activities of complex I, II, and aconitase, which are highly sensitive to oxidative stress [12].”
BackgroundHe, C., Jiang, S., Yao, H., Zhang, L., Yang, C., Jiang, S., Ruan, F., Zhan, D.-L., Liu, G., Lin, Z., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.09.003 · Cited by 34
Hidden phenotypes of PINK1/Parkin knockout mice
Paul, S., & Pickrell, A. M. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129871 · Cited by 36
Vos, M. H., & Klein, C. (2021) · Cells · doi:10.3390/cells10030579 · Cited by 34
Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
Anderson, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010350 · Cited by 33
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease: Insights From PINK1
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 34
“Instead, defects in neurotransmission and synaptic plasticity were prominent; these correlate with increased number of larger but apparently intact and normal mitochondria in the striatum of the mutant mice, presumably caused by imbalanced mitochondrial fission and fusion (29, 30).”
BackgroundInfluentialMitochondrial Targeting in Neurodegeneration: A Heme Perspective
Fiorito, V., Chiabrando, D., & Tolosano, E. (2018) · Pharmaceuticals · doi:10.3390/ph11030087 · Cited by 33
“Similarly, mutations in PINK1 gene lead to decreased mitochondrial respiration [84] and alterations in mitochondria functions [85–88].”
BackgroundWang, Z., Chan, S.-W., Zhao, H., Miu, K.-K., & Chan, W. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.406 · Cited by 33
“Germline deletion of Pink1 in mice significantly impairs mitochondrial functions, with decreased mitochondrial respiration activities but no gross changes in the ultrastructure or number of mitochondria (Gautier et al., 2008).”
BackgroundPlant Polyphenols as Neuroprotective Agents in Parkinson’s Disease Targeting Oxidative Stress
Hor, S. L., Teoh, S. L., & Lim, W. L. (2019) · Current Drug Targets · doi:10.2174/1389450120666191017120505 · Cited by 34
Liu, L., Zhang, X., Zhang, R., Wang, L., Zhi, S., Feng, X., Liu, X., Shen, Y., & Hao, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06179-z · Cited by 32
Ahmad, B., Gamallat, Y., Khan, M. F., Din, S. R. U., Israr, M., Ahmad, M., Tahir, N., Azam, N., Rahman, K. U., Wang, X., et al. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s287354 · Cited by 30
Biomarkers for Parkinson's disease
Graeber, M. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.017 · Cited by 33
Gawęda-Walerych, K., & Żekanowski, C. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1931 · Cited by 31
“…phenotypes as do parkin: a decline in complex I activity, ATP level, MMP, an increase in ROS; without overt DA neuron degeneration (Clark et al. 2006, Park et al. 2006, Yang et al. 2006, Kitada et al. 2007, 2009, Zhou et al. 2007, Gautier et al. 2008, Gispert et al. 2009, Morais et al. 2009).”
BackgroundLoss of the mitochondrial kinase PINK1 does not alter platelet function
Walsh, T. G., van den Bosch, M. T. J., Lewis, K. E., Williams, C. M., & Poole, A. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-32716-4 · Cited by 32
PINK1 deficiency enhances autophagy and mitophagy induction
Gómez‐Sánchez, R., Yakhine-Diop, S. M. S., Pedro, J. M. B., Pizarro‐Estrella, E., Rodríguez‐Arribas, M., Climent, V. E., Martín‐Cano, F. E., González-Soltero, M. E., Tandon, A., Fuentes, J. M., et al. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1046579 · Cited by 35
Verma, M., Zhu, J., Wang, K. Z. Q., & Chu, C. T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010474 · Cited by 29
“Loss of PINK1 function alters mitochondrial clearance, increases the production of reactive oxygen species (14, 17, 18), and renders cells more susceptible to neurotoxicity (19, 20).”
BackgroundMacroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 30
“Although the numbers of dopaminergic neurons remain unaffected by PINK1 depletion, striatal neurons of PINK1−/− mice display a reduced capacity of releasing dopamine [235] and are more susceptible to exogenous stressors as oxidative stress [236].”
BackgroundMora, R. M. S., Arboleda, H., & Arboleda, G. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9687-z · Cited by 29
“PINK1 deficiency promotes increased susceptibility to apoptosis (Deng et al. 2005; Gautier et al. 2008; Valente et al. 2004), whereas overexpression of wild-type PINK1 exercises a neuroprotective effect against various molecules such as MPTP and the proteasome inhibitor MG132 (Haque et al.”
BackgroundKo, J., Park, J. H., Park, Y. S., & Koh, H. C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.08.016 · Cited by 30
Ding, Y., Xin, C., Zhang, C., Lim, K., Zhang, H., Fu, Z., Li, L., & Huang, W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00246 · Cited by 32
“It was showed that the lack of PINK1 resulted in the mitochondrial defects and loss of SNpc DA neurons, and these phenomena could be ameliorated by the enhanced expression of Parkin (Yang et al., 2006; Gautier et al., 2008).”
BackgroundInfluentialTerriente-Félix, A., Wilson, E. L., & Whitworth, A. J. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008844 · Cited by 30
“Studies from a wide 65 variety of model systems have shown various degrees of mitochondrial dysfunction associated with 66 mutation of PINK1/PRKN homologues including disrupted fission/fusion (8-16).”
BackgroundDung, V. M., & Thảo, Đ. T. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_4 · Cited by 28
6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat
Gonçalves, D. F., Courtes, A. A., Hartmann, D. D., da Rosa, P. C., de Oliveira, D. M., Soares, F. A. A., & Corte, C. L. D. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.10.005 · Cited by 29
Brain Mitochondrial Impairment in Early‐Onset Parkinson's Disease With or Without PINK1 Mutation
Rango, M., Dossi, G., Squarcina, L., & Bonifati, C. (2020) · Movement Disorders · doi:10.1002/mds.27946 · Cited by 30
“Experimental models have suggested that PINK1 mutations can cause respiratory chain impairments and deficiencies in adenosine triphosphate (ATP) production, both at rest and when energy demand increases.(15,16) In a preliminary study, we described a subject with a PINK1 mutation that had peculiar in vivo mitochondrial…”
BackgroundUpregulation of human PINK1 gene expression by NFκB signalling
Duan, X., Tong, J., Xu, Q., Wu, Y., Cai, F., Li, T., & Song, W. (2014) · Molecular Brain · doi:10.1186/s13041-014-0057-y · Cited by 28
“died because of its crucial role in autosomal recessive familial Parkinson’s disease [36] and protective role against mitochondrial dysfunction, oxidative stress and apoptosis [37,38].”
BackgroundMitochondrial-Dependent and Independent Functions of PINK1
Chen, X., Wang, Q., Li, S., Li, X., & Yang, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.954536 · Cited by 31
“Consistently, several lines of evidence indicate that PINK1 confers protection against mitochondria dependent apoptosis induced by both intrinsic stress and environmental insults (Gautier et al., 2008; Wang et al., 2011; Huang et al., 2017).”
BackgroundGusdon, A. M., Fernandez‐Bueno, G. A., Wohlgemuth, S. E., Fernandez, J., Chen, J., & Mathews, C. E. (2015) · BMC Biochemistry · doi:10.1186/s12858-015-0051-8 · Cited by 27
Parkinson’s Disease and Autophagy
Sánchez-Pérez, A. M., Clausell, B. C., Sanchez‐Andrés, J. V., & Herrero, M. T. (2012) · Parkinson s Disease · doi:10.1155/2012/429524 · Cited by 29
“This putative role of PINK1 as a “guardian of mitochondrial integrity” seems to be confirmed by reports of PINK1 and parkin knockout models, where an accumulation of damaged mitochondria in various tissues including dopamine neurons occurs [55, 56].”
Background
Metadata
- Authors
- Gautier, C. A., Kitada, T., & Shen, J.
- Affiliations
- Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA 02115
- Brigham and Women's Hospital (US)
- ORCID
- Shen, Jie
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-08-12
- Volume
- 105
- Issue
- 32
- Pages
- 11364-11369
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2516271
- OpenAlex
- W1990287702
- Cited by
- 698
- References
- 39
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 24 · 2023: 29 · 2022: 37 · 2021: 32 · 2020: 48 · 2019: 30 · 2018: 36 · 2017: 33 · 2016: 49 · 2015: 37 · 2014: 46 · 2013: 45 · 2012: 53
- FWCI
- 34.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts Institute of Technology
- National Institute of Neurological Disorders and Stroke (R01NS041779, R01 NS41779)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, Parkinson's disease, mitochondrial dysfunction, mitochondrial respiration, oxidative stress, aconitase, striatum, cerebral cortex, nigrostriatal degeneration, dopaminergic neurons, aging, heat shock, hydrogen peroxide, TCA cycle
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Cerebral Cortex, Citric Acid Cycle, Corpus Striatum, Hydrogen Peroxide, Mitochondria, Oxygen Consumption, Parkinson Disease, Protein Kinases, Time Factors, Gene Deletion, Germ-Line Mutation, Mice, Knockout, Oxidative Stress, Heat-Shock Response, Mitochondrial Proteins, Mitochondrial Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.